TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07802366: XPhe Piccos - Acceptability and Tolerance Market Research

Sponsor: metaX Institut fuer Diatetik GmbH · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 20 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$9,544,800

Rescue Site Savings

+$6,285,600

Unlock Full NCT07802366 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07802366 Rescue Dossier →